Monitoring Agency Report for the quarter ended December 31, 2025
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Artemis Medicare Services has submitted the quarterly Monitoring Agency Report for Q3 FY2026 (quarter ended December 31, 2025) to the stock exchanges, as required under SEBI regulations. This report is typically filed by companies that have raised funds through a public issue, rights issue, or preferential allotment, and it tracks whether the money raised is being used for the stated purposes. The submission itself is a routine compliance requirement and indicates the company has an active fund-raising issue under monitoring. Investors can access the full report on the company's website or stock exchange portals for detailed utilization details.
This is largely a routine compliance filing with no immediate material impact on the stock price. Investors should review the report to verify that proceeds from any prior fund-raising are being deployed as originally disclosed, which is a key governance checkpoint.